CAMKII as a therapeutic target for growth factor–induced retinal and choroidal neovascularization

While anti-VEGF drugs are commonly used to inhibit pathological retinal and choroidal neovascularization, not all patients respond in an optimal manner. Mechanisms underpinning resistance to anti‑VEGF therapy include the upregulation of other proangiogenic factors. Therefore, therapeutic strategies...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:JCI Insight
Autores principales: Ashraf, Sadaf, Bell, Samuel, O’Leary, Caitriona, Canning, Paul, Micu, Ileana, Fernandez, Jose A., O’Hare, Michael, Barabas, Peter, McCauley, Hannah, Brazil, Derek P., Stitt, Alan W., McGeown, J. Graham, Curtis, Tim M.
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society for Clinical Investigation 2019
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6482993/
https://ncbi.nlm.nih.gov/pubmed/30721154
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.122442
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares